Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. Rebello, SS; Kasiewski, CJ; Wang, W; Bentley, RG; Morgan, SR; Chu, V; Colussi, D; Brown, K; Perrone, MH; Leadley, RJ
   Role of short-term inhibition of factor Xa by FXV673 in arterial passivation: A study in a chronic model of thrombosis in conscious dogs
   JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
   
   S.S. Rebello et al., "Role of short-term inhibition of factor Xa by FXV673 in arterial passivation: A study in a chronic model of thrombosis in conscious dogs", J CARDIO PH, 38(2), 2001, pp. 288-297
2. Rebello, SS; Kasiewski, CJ; Bentley, RG; Morgan, SR; Chu, V; Bostwick, JS; Klein, SI; Perrone, MH; Leadley, RJ
   Superiority of enoxaparin over heparin in combination with a GPIIb/IIIa receptor antagonist during coronary thrombolysis in dogs
   THROMBOSIS RESEARCH
   
   S.S. Rebello et al., "Superiority of enoxaparin over heparin in combination with a GPIIb/IIIa receptor antagonist during coronary thrombolysis in dogs", THROMB RES, 102(3), 2001, pp. 261-271
3. Rebello, SS; Bentley, RG; Morgan, SR; Kasiewski, CJ; Chu, V; Perrone, MH; Leadley, RJ
   Antithrombotic efficacy of a novel factor Xa inhibitor, FXV673, in a canine model of coronary artery thrombolysis
   BRITISH JOURNAL OF PHARMACOLOGY
   
   S.S. Rebello et al., "Antithrombotic efficacy of a novel factor Xa inhibitor, FXV673, in a canine model of coronary artery thrombolysis", BR J PHARM, 133(7), 2001, pp. 1190-1198
4. Leadley, RJ; Chi, LG; Rebello, SS; Gagnon, A
   Contribution of in vivo models of thrombosis to the discovery and development of novel antithrombotic agents
   JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS
   
   R.J. Leadley et al., "Contribution of in vivo models of thrombosis to the discovery and development of novel antithrombotic agents", J PHARM TOX, 43(2), 2000, pp. 101-116
5. Rebello, SS; Huang, J; Faul, JD; Lucchesi, BR
   Role of extracellular ionized calcium in the in vitro assessment of GPIIb/IIIa receptor antagonists
   JOURNAL OF THROMBOSIS AND THROMBOLYSIS
   
   S.S. Rebello et al., "Role of extracellular ionized calcium in the in vitro assessment of GPIIb/IIIa receptor antagonists", J THROMB TH, 9(1), 2000, pp. 23-28
6. Rebello, SS; Blank, HS; Lucchesi, BR
   Antithrombotic efficacy of single subcutaneous administration of a recombinant nematode anticoagulant peptide (rNAP5) in a canine model of coronary artery thrombolysis
   THROMBOSIS RESEARCH
   
   S.S. Rebello et al., "Antithrombotic efficacy of single subcutaneous administration of a recombinant nematode anticoagulant peptide (rNAP5) in a canine model of coronary artery thrombolysis", THROMB RES, 98(6), 2000, pp. 531-540
7. Hasan, AAK; Rebello, SS; Smith, E; Srikanth, S; Werns, S; Driscoll, E; Faul, J; Brenner, D; Normolle, D; Lucchesi, BR; Schmaier, AH
   Thrombostatin inhibits induced canine coronary thrombosis
   THROMBOSIS AND HAEMOSTASIS
   
   A.A.K. Hasan et al., "Thrombostatin inhibits induced canine coronary thrombosis", THROMB HAEM, 82(3), 1999, pp. 1182-1187
8. Huang, JB; Rebello, SS; Faul, JD; Lucchesi, BR
   Correlation between the in vivo efficacy of GPIIb/IIIa receptor antagonists (m7E3, MK-383 and DMP-728) and ex vivo platelet inhibition
   PHARMACOLOGY
   
   J.B. Huang et al., "Correlation between the in vivo efficacy of GPIIb/IIIa receptor antagonists (m7E3, MK-383 and DMP-728) and ex vivo platelet inhibition", PHARMACOL, 58(5), 1999, pp. 252-264
9. Rebello, SS; Huang, JB; Saito, K; Saucedo, JF; Bates, ER; Lucchesi, BR
   Effect of time of 7E3 administration on rt-PA-induced reperfusion: study in a canine model of thrombus-based occlusion-reperfusion
   EUROPEAN JOURNAL OF PHARMACOLOGY
   
   S.S. Rebello et al., "Effect of time of 7E3 administration on rt-PA-induced reperfusion: study in a canine model of thrombus-based occlusion-reperfusion", EUR J PHARM, 374(3), 1999, pp. 399-410
10. Huang, JB; Rebello, SS; Rosenberg, LA; Kaneko, M; Sakurama, T; Lucchesi, BR
    Temporary and partial inhibition of platelets by SM-20302 prevents coronary artery thrombosis in a chronic canine model
    EUROPEAN JOURNAL OF PHARMACOLOGY
    
    J.B. Huang et al., "Temporary and partial inhibition of platelets by SM-20302 prevents coronary artery thrombosis in a chronic canine model", EUR J PHARM, 366(2-3), 1999, pp. 203-213
11. REBELLO SS; HUANG JB; SAITO K; LUCCHESI BR
    IN-VIVO EFFICACY OF SM-20302, A GP IIB IIIA RECEPTOR ANTAGONIST, CORRELATES WITH EX-VIVO PLATELET INHIBITION IN HEPARINIZED BLOOD BUT NOT IN CITRATED BLOOD/
    Arteriosclerosis, thrombosis, and vascular biology
    
    S.S. Rebello et al., "IN-VIVO EFFICACY OF SM-20302, A GP IIB IIIA RECEPTOR ANTAGONIST, CORRELATES WITH EX-VIVO PLATELET INHIBITION IN HEPARINIZED BLOOD BUT NOT IN CITRATED BLOOD/", Arteriosclerosis, thrombosis, and vascular biology, 18(6), 1998, pp. 954-960
12. HUANG J; REBELLO SS; FAUL JD; LUCCHESI BR
    CORRELATION BETWEEN THE IN-VIVO EFFICACY OF GPIIB IIIA RECEPTOR ANTAGONISTS AND EX-VIVO PLATELET INHIBITION - ROLE OF CALCIUM/
    The FASEB journal
    
    J. Huang et al., "CORRELATION BETWEEN THE IN-VIVO EFFICACY OF GPIIB IIIA RECEPTOR ANTAGONISTS AND EX-VIVO PLATELET INHIBITION - ROLE OF CALCIUM/", The FASEB journal, 12(4), 1998, pp. 1113-1113
13. REBELLO SS; HUANG JB; SHIN WJ; SAITO K; KANEKO M; SAITOH Y; LUCCHESI BR
    PHARMACOKINETICS AND PHARMACODYNAMICS OF SM-20302, A GPIIB IIIA RECEPTOR ANTAGONIST, IN ANESTHETIZED DOGS/
    Journal of cardiovascular pharmacology
    
    S.S. Rebello et al., "PHARMACOKINETICS AND PHARMACODYNAMICS OF SM-20302, A GPIIB IIIA RECEPTOR ANTAGONIST, IN ANESTHETIZED DOGS/", Journal of cardiovascular pharmacology, 32(3), 1998, pp. 485-494
14. REBELLO SS; MILLER BV; BASLER GC; LUCCHESI BR
    CVS-1123, A DIRECT THROMBIN INHIBITOR, PREVENTS OCCLUSIVE ARTERIAL AND VENOUS THROMBOSIS IN A CANINE MODEL OF VASCULAR INJURY
    Journal of cardiovascular pharmacology
    
    S.S. Rebello et al., "CVS-1123, A DIRECT THROMBIN INHIBITOR, PREVENTS OCCLUSIVE ARTERIAL AND VENOUS THROMBOSIS IN A CANINE MODEL OF VASCULAR INJURY", Journal of cardiovascular pharmacology, 29(2), 1997, pp. 240-249
15. REBELLO SS; DRISCOLL EM; LUCCHESI BR
    TP-9201, A GLYCOPROTEIN IIB IIIA PLATELET RECEPTOR ANTAGONIST, PREVENTS RETHROMBOSIS AFTER SUCCESSFUL ARTERIAL THROMBOLYSIS IN THE DOG/
    Stroke
    
    S.S. Rebello et al., "TP-9201, A GLYCOPROTEIN IIB IIIA PLATELET RECEPTOR ANTAGONIST, PREVENTS RETHROMBOSIS AFTER SUCCESSFUL ARTERIAL THROMBOLYSIS IN THE DOG/", Stroke, 28(9), 1997, pp. 1789-1796
16. REBELLO SS; BLANK HS; ROTE WE; VLASUK GP; LUCCHESI BR
    ANTITHROMBOTIC EFFICACY OF A RECOMBINANT NEMATODE ANTICOAGULANT PEPTIDE (RNAP5) IN CANINE MODELS OF THROMBOSIS AFTER SINGLE SUBCUTANEOUS ADMINISTRATION
    The Journal of pharmacology and experimental therapeutics
    
    S.S. Rebello et al., "ANTITHROMBOTIC EFFICACY OF A RECOMBINANT NEMATODE ANTICOAGULANT PEPTIDE (RNAP5) IN CANINE MODELS OF THROMBOSIS AFTER SINGLE SUBCUTANEOUS ADMINISTRATION", The Journal of pharmacology and experimental therapeutics, 283(1), 1997, pp. 91-99
17. REBELLO SS; LUCCHESI BR
    SIGNIFICANCE OF FACTOR XA INHIBITION IN A CANINE MODEL OF CORONARY-THROMBOSIS - EFFECTS OF RECOMBINANT NEMATODE ANTICOAGULANT PEPTIDE (RNAP5)
    The FASEB journal
    
    S.S. Rebello e B.R. Lucchesi, "SIGNIFICANCE OF FACTOR XA INHIBITION IN A CANINE MODEL OF CORONARY-THROMBOSIS - EFFECTS OF RECOMBINANT NEMATODE ANTICOAGULANT PEPTIDE (RNAP5)", The FASEB journal, 10(3), 1996, pp. 2504-2504
18. HASAN AA; REBELLO SS; WAHL R; FISHER SJ; LUCCHESI BR; SCHMAIER AH
    THROMBOSTATIN - IN-VIVO CLEARANCE AND EFFECT OF THIS THROMBIN RECEPTOR INHIBITOR
    Circulation
    
    A.A. Hasan et al., "THROMBOSTATIN - IN-VIVO CLEARANCE AND EFFECT OF THIS THROMBIN RECEPTOR INHIBITOR", Circulation, 94(8), 1996, pp. 1339-1339
19. REBELLO SS; LUCCHESI BR
    RECOMBINANT NEMATODE ANTICOAGULANT PEPTIDE (RNAP5), A SELECTIVE FACTOR XA INHIBITOR, PREVENTS CANINE CORONARY-ARTERY THROMBOSIS
    Circulation
    
    S.S. Rebello e B.R. Lucchesi, "RECOMBINANT NEMATODE ANTICOAGULANT PEPTIDE (RNAP5), A SELECTIVE FACTOR XA INHIBITOR, PREVENTS CANINE CORONARY-ARTERY THROMBOSIS", Circulation, 94(8), 1996, pp. 1562-1562
20. COUSINS GR; FRIEDRICHS GS; SUDO Y; REBELLO SS; ROTE WE; VLASUK GP; NOLAN TG; MENDOZA C; LUCCHESI BR
    ORALLY EFFECTIVE CVS-1123 PREVENTS CORONARY-ARTERY THROMBOSIS IN THE CONSCIOUS DOG
    Circulation
    
    G.R. Cousins et al., "ORALLY EFFECTIVE CVS-1123 PREVENTS CORONARY-ARTERY THROMBOSIS IN THE CONSCIOUS DOG", Circulation, 94(7), 1996, pp. 1705-1712